Teresa Lopez-Castro to Opioid-Related Disorders
This is a "connection" page, showing publications Teresa Lopez-Castro has written about Opioid-Related Disorders.
Connection Strength
1.315
-
L?pez-Castro T, Jakubowski A, Masyukova M, Peterson M, Pierz A, Kodali S, Arnsten JH, Starrels JL, Nahvi S. Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic. J Subst Use Addict Treat. 2024 02; 157:209235.
Score: 0.668
-
L?pez-Castro T, Sohler N, Riback L, Bravo G, Ohlendorf E, Ghiroli M, Fox AD. Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care. Harm Reduct J. 2024 06 01; 21(1):108.
Score: 0.173
-
Saraiya TC, Jones AC, Lopez-Castro T, Hood CO, Flores J, Badour CL. Trauma-related shame predicts daily non-medical prescription opioid use among individuals with PTSD symptoms. J Psychiatr Res. 2024 03; 171:171-176.
Score: 0.169
-
Ohlendorf E, Perez-Correa A, Riback L, Ghiroli M, Lopez-Castro T, Fox AD. Treatment History and Interest in Injectable Opioid Agonist Treatment With Hydromorphone Among People Who Inject Drugs. J Addict Med. 2023 May-Jun 01; 17(3):e148-e155.
Score: 0.154
-
Jakubowski A, Rath C, Harocopos A, Wright M, Welch A, Kattan J, Navos Behrends C, Lopez-Castro T, Fox AD. Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation. Harm Reduct J. 2022 07 10; 19(1):75.
Score: 0.152